Immune-Related Adverse Events When Using Immunotherapy to Treat Cancer

Dr Gareth Rivalland, Medical Oncologist, Auckland

Immune-Related Adverse Events When Using Immunotherapy to Treat Cancer




This video was supported by an independent educational grant provided from Merck Sharp & Dohme (New Zealand) Limited, a subsidiary of Merck & Co., Inc., Rahway., New Jersey, USA (MSD).  

MSD selected the topic of this video but had no involvement in the creation of the content. The content is entirely independent and based on the speaker’s opinions. Please consult the relevant Data Sheet for any medications mentioned at www.medsafe.govt.nz before prescribing. Treatment decisions based on this data are the full responsibility of the prescribing healthcare professional.





Merck Sharpe & Dohme (New Zealand) Ltd

Level 3, 123 Carlton Gore Road
Newmarket, Auckland